Overview

OrthoCell is a technology development company seeking to address unmet clinical needs within the orthopaedics sector, focused on biological therapies for tissue repair and regeneration.

Business Opportunities (i.e Partner, Joint Venture, Distributor, Agent, End User)

Orthocell is looking to develop licencing oportunities for its technologies and to further develop commercial and scientific collaborations.

Technology/Products and Services Description

The development of its core technology will deliver the first truly effective clinical cellular therapeutic regeneration solution for the treatment of rotator cuff failure within the shoulder joint and other tendonopathy related injuries. OrthoCell’s technology is at an advanced stage of development, with strong Proof of concept trial results, which indicate that the technology will immediately fill an unmet clinical need, and inherent performance failures of existing technologies.

OrthoCell also provides an incubator for enhanced local product and Intellectual Property development via the design, construction and management of its Good Manufacturing Practice (GMP) Facility. The  GMP facility  addresses identified critical bottlenecks in the trialing and commercialisation of  developeding bio-therapeutic technologies by providing the infrastructure necessary to conduct clinical trials of newly  developed cellular therapies.

Competitive Advantages

OrthoCell’s  combines the outstanding technical and market credentials of its management / executive with a state of the art fully operational GMP facility, to fully integrated with the local Biotherapeutic research sector, in order to de-risk and add value to early stage biotherapeutic technologies. OrthoCell will provide the critical enabling infrastructure, market intelligence and access capability to realize the commercial potential of its exciting new technology developments with first to market advantages.